BRIEF-Couche-Tard Still Seeking Seven & I Deal, Access To Financials - Bloomberg News-February 2024-www.financetom.com

BRIEF-Couche-Tard Still Seeking Seven & I Deal, Access To Financials - Bloomberg News

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Couche-Tard Still Seeking Seven & I Deal, Access To Financials - Bloomberg News

Feb 26, 2025 7:17 AM

Feb 26 (Reuters) - Seven & i Holdings Co Ltd ( SVNDF ):

* COUCHE-TARD STILL SEEKING SEVEN & I DEAL, ACCESS TO

FINANCIALS -

BLOOMBERG NEWS

Source text: https://tinyurl.com/5n8czmms

Further company coverage:

Previous page： Super Bowl audience sets all-time record for a single-network broadcast Next page： Sensata Technologies Q4 Adjusted Earnings, Revenue Decline; Sets Q1 Guidance -- Shares Jump

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Super Bowl audience sets all-time record for a single-network broadcast

Feb 11, 2025

LOS ANGELES, Feb 11 (Reuters) - An estimated 127.7 million viewers tuned in for Sunday's Super Bowl championship, the largest audience in TV history for a single-network telecast, the Nielsen ratings agency said on Tuesday. ...

Sensata Technologies Q4 Adjusted Earnings, Revenue Decline; Sets Q1 Guidance -- Shares Jump

Feb 11, 2025

04:14 PM EST, 02/11/2025 (MT Newswires) -- Sensata Technologies ( ST ) reported Q4 adjusted earnings late Tuesday of $0.76 per diluted share, down from $0.81 a year earlier. Analysts polled by FactSet expected $0.75. Revenue for the quarter ended Dec. 31 fell to $907.7 million from $992.5 million a year earlier. Analysts surveyed by FactSet expected $884.9 million. For...

Edwards Lifesciences beats profit estimate on strength in heart devices

Feb 11, 2025

Feb 11 (Reuters) - Edwards Lifesciences ( EW ) beat analysts' estimate for fourth-quarter profit on Tuesday, helped by strong demand for its artificial heart valves and other medical devices. Investors remain bullish on medical device makers, expecting them to benefit from still-high demand for surgical procedures, especially from older adults. Last week, larger peer Boston Scientific ( BSX )...

Chewy Insider Sold Shares Worth $2,513,166, According to a Recent SEC Filing

Feb 11, 2025

04:13 PM EST, 02/11/2025 (MT Newswires) -- Satish Mehta, Chief Technology Officer, on February 07, 2025, sold 66,258 shares in Chewy (CHWY) for $2,513,166. Following the Form 4 filing with the SEC, Mehta has control over a total of 557,991 Class A common shares of the company, with 557,991 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1766502/000112760225004134/xslF345X05/form4.xml ...